The Karma Continues: Things Get Even Worse For Martin Shkreli

Gigantic douchebag Martin Shkreli, the ‘pharma bro’ who thought it was a cool idea to raise the price of a life saving drug by 5500%, is not having a good week.

On top of being arrested for a Ponzi scheme he set up at his former hedge fund, stepping down as CEO from his former pharmaceutical company Turing Pharmaceuticals, Shkreli has now been fired from his post as CEO of another company he worked for, KaloBios Pharmaceuticals, a San Francisco-based pharma company specializing in treatments for rare and orphaned diseases.

According to CNBC:

On Monday, the company said Shkreli was “terminated” as CEO and had resigned from the board.

It is difficult to feel sorry for a man who not only had such little regard for the welfare of the most vulnerable people on the planet, but also lied about reversing his position after the public backlash. After stating he would lower the price of Daraprim, the drug that helps keep HIV victims alive, Shkreli decided he wouldn’t after all as soon as the media attention died down.

Unfortunately for him, the federal government clearly took note of his astonishingly assholish ways and decided to take a closer look at his financial dealings, only to discover that there were enough grounds to take him in and charge him with securities fraud.

If convicted, Shkreli stands to spend up to 20 years in prison. And if he doesn’t, he won’t have much of a career left anyway, so it’s safe to say we’ve heard the last of his predatory capitalism.

Ben Cohen is the editor and founder of The Daily Banter. He lives in Washington DC where he does podcasts, teaches Martial Arts, and tries to be a good father. He would be extremely disturbed if you took him too seriously.